Status:
RECRUITING
Prospective Breast Cancer Biospecimen Collection
Lead Sponsor:
Thomas Jefferson University
Conditions:
Breast Cancer
Invasive Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome...
Detailed Description
This is a breast cancer biospecimen and possible metastasis procurement study with the goal of obtaining specimens appropriately for genomic and proteomic analysis. Other than reviewing and signing th...
Eligibility Criteria
Inclusion
- Adults \>18 years old at time of consent
- Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
- Patients with carcinoma in situ or invasive breast cancer
- Patient must be undergoing one of the following:
- definitive surgical tumor resection for breast cancer OR
- placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
- neurosurgical resection of a brain metastasis from primary breast cancer.
Exclusion
- \<18 years old
- Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
- Active drug/alcohol dependence or abuse history
Key Trial Info
Start Date :
May 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04074720
Start Date
May 10 2018
End Date
July 1 2028
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107